A Ten-Patient Case Study Series on the Impact of a 100% Chitosan-Based Dressing

The Impact of a 100% Chitosan-Based Dressing with Bioactive Microfibre Gelling (BMG™) Technology and the Importance of Education in the Management of Oncology Wounds

Wound Healing Progression – Out of 10 patients, 7 showed healing, 2 were nearly healed, and 1 remained non-healing.
Wound Size Reduction – Average wound area decreased from 51cm² to 44cm² over four weeks.
Tissue Composition Improvement – Granulation and epithelialization tissue increased from 34.5% to 68.5%, while slough and necrotic tissue decreased from 65.5% to 25.5%.
Periwound Skin Health – Maceration and excoriation reduced from 70% to 0%, while healthy periwound skin increased from 10% to 70%.
Pain levels dropped from 6 to 2 (VAS scale), and odour was significantly reduced, improving patient confidence.

MaxioCel® provided effective exudate management, pain relief, and infection control, significantly improving quality of life for oncology patients.
Its biocompatibility and antimicrobial properties support wound healing, even in palliative and active cancer care.
The study highlights the critical role of clinician education in improving oncology wound management, reinforcing the need for best-practice sharing.

Evaluation of a 100% Chitosan Dressing in the Treatment of Diabetic Foot Ulcers

Chronic Wound Debridement in an Acute Setting

Severe Pressure Ulcer Debridement in the Acute Sector

A Multi-disciplinary Team Approach to the Management